Arterial concentration of 99mTc-sestamibi at rest, during peak exercise and after dipyridamole infusion

Clinical Physiology and Functional Imaging

Volumn 24, Issue 6, 2004, Pages 394-397

  Sand, Niels Peter Rønnow ^a   Juelsgaard, Palle ^a   Rasmussen, Karin ^a   Flø, Christian ^a   Thuesen, Leif ^a   Bagger, Jens Peder ^a   Nielsen, Torsten Toftegaard ^a   Rehling, Michael ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Arterial concentration; Blood clearance; Myocardial perfusion; Perfusion imaging; Stress testing; Time activity curve; Tracerkinetics

Indexed keywords

DIPYRIDAMOLE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ANGINA PECTORIS; ARTERIAL BLOOD; ARTICLE; BICYCLE ERGOMETRY; BLOOD SAMPLING; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DRUG TISSUE LEVEL; EXERCISE; FEMORAL ARTERY; HEMODYNAMICS; HUMAN; PLASMA CLEARANCE; PRIORITY JOURNAL; RADIAL ARTERY; REST; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TRANSLUMINAL CORONARY ANGIOPLASTY; ARTERY; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; EXERCISE TEST; INTRAARTERIAL DRUG ADMINISTRATION; METABOLIC CLEARANCE RATE; METABOLISM; METHODOLOGY; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

ARTERIES; CORONARY ARTERIOSCLEROSIS; DIPYRIDAMOLE; EXERCISE TEST; HUMANS; INFUSIONS, INTRA-ARTERIAL; METABOLIC CLEARANCE RATE; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; REST; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 8844231755     PISSN: 14750961     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1475-097X.2004.00570.x     Document Type: Article

References (10)

1. Bisi G, Sciagra R, Santoro GM, Briganti V, Leoncini M, Fazzini PF. Evaluation of coronary artery disease extent using 99m-Tc-sestamibi: comparison of dipyridamole versus exercise and of planar versus tomographic imaging. Nucl Med Commun (1993); 14 946-954.
2. Braat SH, De Swart H, Rigo P, Koppejan L, Heidendal GAK, Wellens HJJ. Value of technetium MIBI to detect short lasting episodes of severe myocardial ischaemia and to estimate the area at risk during coronary angioplasty. Eur Heart J (1991); 12: 30-33.
3. Crane P, Laliberté R, Heminway S, Thoolen M, Orlandi C. Effect of mitochondrial viability and metabolism on technetium-99m-sestamibi myocardial retention. Eur J Nucl Med (1993); 20: 20-25.
4. Okada RD, Glover DK, Nguyen KN, Johnson G. Technetium-99m sestamibi kinetics in reperfused canine myocardium. Eur J Nucl Med (1995); 22: 600-607.
5. Pfisterer M, Müller-Brand J, Spring P, Bassignana V, Kiowski W. Assessment of the extent of jeopardised myocardium during acute coronary artery occlusion followed by reperfusion in man using technetium-99m isonitrile imaging. Am Heart J (1991); 122: 7-12.
6. Piwnica-Worms D, Kronauge JF, Chiu ML. Uptake and retention of hexakis (2-methoxyisobutyl isonitril) technetium (I) in cultured chick myocardial cells. Circulation (1990); 82: 1826-1838.
7. Primeau M, Taillefer R, Essiambre R, Lambert R, Honos G. Technetium 99m sestamibi myocardial perfusion imaging: comparison between treadmill, dipyridamole and trans-oesophageal atrial pacing stress tests in normal subjects. Eur J Nucl Med (1991); 18: 247-251.
8. 99mTc-sestamibi SPECT. J Am Coll Cardiol (2000); 35: 624-632.
9. Savi A, Gerundini P, Zoli P, Maffioli L, Compierchio A, Colombo F, Matarrese M, Deutsch E. Biodistribution of Tc-99m methoxy-isobutyl-isonitril (MIBI) in humans. Eur J Nucl Med (1989 ; 15: 597-600.
10. Wackers FJ, Berman DS, Maddahi J, Watson DD, Beller GA, Strauss HW, Boucher CA, Picard M, Holman BL, Fridrich R, Inglese E, Dlaloye B, Bischof-Delaloye A, Camin L, McKusick K. Technetium-99m Hexakis 2-Methoxyisobutyl Isonitril: Human Biodistribution, Dosimetry, Safety, and preliminary comparison to Thallium-201 for myocardial perfusion imaging. J Nucl Med (1989); 30: 301-311.